CD47 expression levels may predict evorpacept efficacy in HER2-positive metastatic breast cancer, especially in heavily pretreated patients. Evorpacept combined with zanidatamab shows promising ...
Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.
Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...
Discover how antibody-drug conjugates (ADCs) are transforming treatment strategies for gastrointestinal cancers, enhancing ...
A new study published in The New England Journal of Medicine found HER2-positive metastatic breast cancer to show that the ...
It seems there is no text provided for summarization. Please share the content you'd like summarized, and I'll be happy to help!
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Adopted Names (USAN ...
Explore how claudin-18.2 can transform cancer treatment for gastric and pancreatic tumours using targeted radiotherapy.
A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, ...
The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...
2hon MSN
Modern cancer care explained: How robotic surgery and new therapies preserve quality of life
Modern cancer care has shifted toward a patient-centred approach that focuses on early detection, prevention, and preserving ...
Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results